Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 3 » Issue 1

Cardiovascular morbidity and the use of inhaled bronchodilators

Authors Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen

Published 7 March 2008 Volume 2008:3(1) Pages 163—169

DOI https://doi.org/10.2147/COPD.S1516

Christine Macie, Kate Wooldrage, Jure Manfreda, Nicholas Anthonisen

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

Abstract: We used the Manitoba Health database to examine the relationship between use of inhaled respiratory drugs in people with chronic obstructive respiratory diseases and cardiovascular hospitalizations from 1996 through 2000. The drugs examined were beta agonists [BA], ipratropium bromide IB, and inhaled steroids (ICS). End points were first hospitalizations for supraventricular tachycardia, myocardial infarction, heart failure or stroke. A nested case control analysis was employed comparing people with and without cardiovascular events. Cases and controls were matched for gender and age, and conditional logistic regression was used in multivariate analysis considering other respiratory drugs, respiratory diagnosis and visit frequency, non-respiratory, non-cardiac comorbidities, and receipt of drugs for cardiovascular disease. In univariate analyses, BA, IB and ICS were all associated with hospitalizations for cardiovascular disease, but in multivariate analyses ICS did not increase risk while both BA and IB did. There were interactions between respiratory and cardiac drugs receipt in that bronchodilator associated risks were higher in people not taking cardiac drugs; this was especially true for stroke. There were strong interactions with specific cardiac drugs; for example, both BA and IB substantially increased the risk of supraventricular tachycardia in patients not anti-arryhthmic agents, but not in the presence of such agents. We conclude that bronchodilator therapy for chronic obstructive diseases is associated with increased cardiovascular risk, especially in patients without previous cardiovascular diagnoses, and that this is unlikely due to the severity of the respiratory disease, since risk was not increased with ICS.

Keywords: bronchodilator therapy, inhaled corticosteroids, nested case control study

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Mechanisms of atherothrombosis in chronic obstructive pulmonary disease

Filippo Luca Fimognari, Simone Scarlata, Maria Elisabetta Conte, Raffaele Antonelli Incalzi

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:89-96

Published Date: 7 March 2008

Optimizing antibiotic selection in treating COPD exacerbations

Attiya Siddiqi, Sanjay Sethi

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:31-44

Published Date: 7 March 2008

Impact of laughter on air trapping in severe chronic obstructive lung disease

Martin H Brutsche, Paul Grossman, Rebekka E Müller, Jan Wiegand, Pello, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:185-192

Published Date: 7 March 2008

Non-invasive biomarkers and pulmonary function in smokers

Zoë L Borrill, Kay Roy, Rupert S Vessey, Ashley A Woodcock, Dave Singh

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:171-183

Published Date: 7 March 2008

Effect of add-on therapy of tiotropium in COPD treated with theophylline

Tomotaka Kawayama, Tomoaki Hoshino, Masao Ichiki, Toru Tsuda, Masaharu Kinoshita, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:137-147

Published Date: 7 March 2008

Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease

Antonia Fuster, Jaume Sauleda, Ernest Sala, Bernardí Barceló, Jaume Pons, et al

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:149-153

Published Date: 7 March 2008

Pulmonary hypertension associated with COPD

Jean Elwing, Ralph J Panos

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:55-70

Published Date: 7 March 2008

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium

Cristoforo Incorvaia, Gian Galeazzo Riario-Sforza, Chiara Pravettoni, Mona-Rita Yacoub, Franco Frati

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:123-126

Published Date: 7 March 2008

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients

Steven Kesten, Richard Casaburi, David Kukafka, Christopher B Cooper

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:127-136

Published Date: 7 March 2008